Can keytruda dosage be adjusted based on patient's weight?

Can Keytruda (pembrolizumab) dosing be adjusted by a patient’s weight?

Keytruda dosing is not adjusted based on body weight. The standard prescribing approach uses fixed dosing based on either a weight-independent every-3-weeks schedule or a flat every-6-weeks schedule (depending on the regimen), rather than calculating a dose per kilogram.

What dosing schedules are used instead of weight-based calculations?

Clinicians typically use one of Keytruda’s approved fixed-dose regimens, selected according to the cancer type and treatment setting. Those regimens are defined as set milligram doses for the infusion interval, not as mg/kg.

Are there any situations where clinicians change the amount for a patient?

The dose for Keytruda is generally kept fixed by the label regimen, but clinicians may delay treatment or discontinue it based on side effects (for example, immune-related toxicities) rather than changing the dose according to weight.

Sources

• [1] DrugPatentWatch.com (Keytruda/pembrolizumab listing and related regulatory/patent context): https://www.drugpatentwatch.com/p/patent-product/keytruda